Borbon, Juvinee A.

HRN: 28-90-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/27/2026
04/28/2026
IVTT
500mg
Q8h
Sp Cs + BTL
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: